Pediatrix Medical Group, Inc. (MD) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Pediatrix Medical Group’s revenue went from $3.2B in fiscal 2016 to $1.9B in fiscal 2025, a decline of about 5.5% a year.
Net income in fiscal 2025 was $165M, a net margin of 8.6%; the best year in this period was 2016 with $325M.
Over the twelve months to September 30, 2026, revenue was $2.0B and net income $150M.
Free cash flow was $253M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 8% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0B | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B | $1.7B | $1.8B | $1.7B | $3.5B | $3.2B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $213M | $209M | -$69M | $7M | $173M | $203M | $98M | $172M | $248M | $455M | $572M |
| Net income | $150M | $165M | -$99M | -$60M | $66M | $131M | -$796M | -$1.5B | $269M | $320M | $325M |
| EPS (diluted) | $1.84 | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 | $-9.55 | $-17.83 | $2.93 | $3.45 | $3.49 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | −4.9% | +0.9% | +1.1% | +3.2% | +10.2% | −2.6% | +3.3% | −50.2% | +8.6% | +14.5% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $227M | $271M | $207M | $137M | $167M | $77M | $205M | $358M | $314M | $511M | $444M |
| Capital spending | -$17M | -$18M | -$22M | -$33M | -$30M | -$32M | -$29M | -$19M | -$17M | -$26M | -$39M |
| Free cash flow | $210M | $253M | $185M | $104M | $137M | $44M | $176M | $338M | $297M | $485M | $405M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $211M | $87M | $2M | $919000 | $89M | $5M | $8M | $145M | $302M | $70M | $62M |
| Stock-based pay | $21M | $18M | $12M | $12M | $16M | $19M | $39M | $33M | $37M | $29M | $34M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $500M | $349M | $178M | $103M | $487M | $1.2B | $108M | $63M | $51M | $67M |
| Debt | — | $635M | $662M | $702M | $713M | $1.1B | $1.8B | $1.8B | $2.0B | $1.8B | $1.7B |
| Equity | — | $866M | $765M | $849M | $892M | $896M | $747M | $1.5B | $3.1B | $3.1B | $2.8B |
| Total assets | — | $2.2B | $2.2B | $2.2B | $2.3B | $2.7B | $3.3B | $4.1B | $5.9B | $5.9B | $5.3B |
| Shares (diluted) | 80M | 85M | 83M | 82M | 84M | 86M | 83M | 84M | 92M | 93M | 93M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 10.9% | 10.9% | -3.4% | 0.4% | 8.8% | 10.6% | 5.7% | 9.7% | 14.4% | 13.2% | 18.0% |
| Net margin | 7.7% | 8.6% | -4.9% | -3.0% | 3.4% | 6.9% | -45.9% | -84.2% | 15.6% | 9.3% | 10.2% |
| FCF margin | 10.7% | 13.2% | 9.2% | 5.2% | 7.0% | 2.3% | 10.1% | 19.0% | 17.2% | 14.0% | 12.7% |
| ROIC | — | 10.6% | -4.7% | 0.4% | 8.3% | 8.3% | 3.1% | 3.8% | 3.6% | 7.3% | 8.1% |
| ROE | — | 19.1% | -13.0% | -7.1% | 7.4% | 14.6% | -106.6% | -99.9% | 8.7% | 10.4% | 11.8% |
Frequently asked questions
What is Pediatrix Medical Group’s annual revenue?
$1.9B in fiscal 2025 and $2.0B over the twelve months to September 30, 2026.
How much profit does Pediatrix Medical Group make?
Net income was $165M in fiscal 2025 (net margin 8.6%).
Is Pediatrix Medical Group’s revenue growing?
No: revenue fell 4.9% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.